Keyphrases
Prostaglandin F2α
100%
Asthmatic
100%
Urinary Leukotriene E4
100%
Blood Eosinophil Count
100%
Asthma Exacerbation
100%
Peripheral Eosinophil Count
57%
Odds Ratio
28%
Objective Assessment
28%
Asthma Control Status
28%
Treatment Duration
14%
Receiver Operating Characteristic Curve
14%
Area under the Curve
14%
Budesonide
14%
Cognitive Function
14%
Current Guidelines
14%
Time-of-flight Mass Spectrometry
14%
Elderly Subjects
14%
Control Evaluation
14%
Metabolite Concentrations
14%
Ultra-high Performance Liquid Chromatography (UHPLC)
14%
Cognitive Effort
14%
Inhaled Budesonide
14%
Sputum Eosinophil Count
14%
Montelukast
14%
Asthma Control
14%
Global Initiative for Asthma Guidelines
14%
Immunology and Microbiology
Blood Plasma
100%
Prostaglandin F2
100%
Asthma
100%
Leukotriene E4
100%
Eosinophil Count
100%
Asthma Exacerbation
100%
Budesonide
28%
Metabolite
14%
Sputum
14%
Cognition
14%
Ultra High Performance Liquid Chromatography
14%
Montelukast
14%
Pharmacology, Toxicology and Pharmaceutical Science
Asthma
100%
Prostaglandin F2
100%
Leukotriene E4
100%
Budesonide
14%
Ultra High Performance Liquid Chromatography
7%
Montelukast
7%
Biochemistry, Genetics and Molecular Biology
Leukotriene E4
100%
Budesonide
33%
Food Science
Ultra High Performance Liquid Chromatography
100%